NCT05917184View on ClinicalTrials.gov

The Adapting Disease Specific Outcome Measures Pilot Trial for Telehealth in Myasthenia Gravis

CompletedOBSERVATIONAL
Enrollment

52

Participants

Timeline

Start Date

August 30, 2021

Primary Completion Date

January 20, 2023

Study Completion Date

January 20, 2023

Conditions
Myasthenia Gravis
Interventions
OTHER

Telehealth

Two video telehealth visits will be conducted and recorded within 3 days of one another (+/- 1 day)

Trial Locations (5)

20037

George Washington University, Washington D.C.

27710

Duke University Medical Center, Durham

60637

University of Chicago, Chicago

06519

Yale University, New Haven

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

collaborator

National Center for Advancing Translational Sciences (NCATS)

NIH

lead

Yale University

OTHER

NCT05917184 - The Adapting Disease Specific Outcome Measures Pilot Trial for Telehealth in Myasthenia Gravis | Biotech Hunter | Biotech Hunter